Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-04-11 | Mr. Herring also brings to the Company’s Board of Directors comprehensive knowledge in pharmaceuticals, management, sales and corporate governance matters. |
| 2017-04-10 | Mr. Herring has more than 35 years of experience in the healthcare industry and comprehensive knowledge in pharmaceuticals, management, sales and corporate governance. |
| 2018-04-12 | Mr. Herring served as Chief Executive Officer of Covance Inc., a drug development services company, and has comprehensive knowledge in pharmaceuticals, management, sales and corporate governance. |
| 2019-04-09 | Mr. Herring also brings to the Company’s Board of Directors comprehensive knowledge in pharmaceuticals, management, sales and corporate governance matters. |
| 2020-04-07 | Mr. Herring brings to the Company’s Board of Directors comprehensive knowledge in pharmaceuticals, management, sales and corporate governance matters. |
| 2021-03-30 | Mr. Herring brings to the Company’s Board of Directors comprehensive knowledge in pharmaceuticals, management, sales and corporate governance matters. |
| 2022-04-06 | Mr. Herring also brings to the Company’s Board of Directors comprehensive knowledge in pharmaceuticals, management, sales and corporate governance matters. |
| 2023-04-11 | Mr. Herring also brings to the Company’s Board of Directors comprehensive knowledge in pharmaceuticals, management, sales and corporate governance matters. |
| 2024-04-10 | Mr. Herring also brings to the Company’s Board of Directors comprehensive knowledge in pharmaceuticals, management, sales and corporate governance matters. |
Data sourced from SEC filings. Last updated: 2025-10-11